Exploring the link between respiratory microbiome and severe asthma in young children
Official title: Respiratory Dysbiosis in Preschool Children with Asthma: Predictive of a Severe Form
Run by University Hospital, Brest · NCT05192499 · Data updated 2026-11-12
This study is trying to see if the germs in the lungs of young children with severe asthma can help predict how well they respond to treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 1 Year to 3 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | University Hospital, Brest Academic / other |
| Locations | 1 site (Brest, Finistère) |
| Status | Recruiting |
| Started | February 4, 2022 |
| Main results expected | February 4, 2028 |
| Study ends | February 4, 2028 |
| Registry record updated | September 23, 2024 |
| Trial ID | NCT05192499 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children aged 1 to 3 years diagnosed with asthma who have parental consent.
✕Probably not a fit
Patients with chronic pathologies such as cystic fibrosis or congenital heart disease, or those who have recently undergone antibiotic therapy, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the relationship between respiratory dysbiosis and severe asthma in preschool children under 3 years old. It aims to identify a microbiological signature that may predict corticosteroid resistance in these patients. The research employs a multicentric prospective case-control design, utilizing stool tests, blood tests, induced sputum, and nasal virology to gather data. The goal is to better understand how variations in the respiratory microbiome may influence asthma severity and treatment efficacy.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies for young children with severe asthma, potentially reducing corticosteroid resistance.
How similar studies have gone: While the approach of using microbiota as a biomarker in asthma management is relatively novel, similar studies in cystic fibrosis have shown promising results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age greater than 1 year and less than 3 years * Diagnosis of asthma by a pediatrician * Parental consent * Affiliation to the social security system Exclusion Criteria: * Chronic pathologies: congenital heart disease, immune deficiency, cystic fibrosis, bronchopulmonary dysplasia, encephalopathy, primary ciliary dyskinesia, laryngomalacia, digestive pathology requiring digestive surgery * Premature \< 34 SA * Recent antibiotic therapy (\< 7 days) * Treatment with oral corticosteroid therapy within the previous 10 days. * Patient whose parent(s) is (are) minor(s)
Where it's running
-
CHU de Brest
Brest, Finistère, France Recruiting
Study contacts
- Study coordinator: Pierrick CROS
- Email: pierrick.cros@chu-brest.fr
- Phone: 02 98 22 36 59
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effect of Periodontal Therapy on Gut Microbes and Inflammation in People with Inflammatory Bowel Disease
This study tests whether treating gum disease in people with inflammatory bowel disease can influence the gut microbiome and markers of systemic inflammation.
-
N-WATCH: Can a simple breath device help monitor asthma in kids
This study tests the N-Tidal C device to see if it helps monitor asthma in children aged 5 to under 16 who have wheeze or asthma and are not critically ill.
-
Smart Inhaler Use at Home for Adolescents with IDD and Asthma
This study tests whether daily use of active smart inhalers at home helps adolescents with intellectual disabilities manage asthma better.
-
Metabolic and Functional Study of γδ T Cells in Critically Ill Patients
Researchers will look at how γδ T cells behave in severely ill patients, including those with sepsis, to see how their metabolism and function change.
-
Pulse-focused nutrition for school-age children
This 6-week program tests whether a pulse-based diet (1.5 cups per week) improves gut health and metabolic markers in kids aged 6–13 who receive either pulses with education or pulses plus education and procurement support.
-
Almonds, Gut Microbiome, and Kids
This 8-week study tests whether a daily almond butter snack can favorably impact gut bacteria and metabolic health in children aged 6–13 compared with a chocolate spread control.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.